|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Pharmaceutical Sciences, Wayne State University and
Cell Biochemistry Research Laboratory, Detroit, MI, USA
* To whom correspondence should be addressed. E-mail: akowluru{at}med.wayne.edu.
We recently described novel regulatory roles for protein histidine phosphorylation of key islet proteins [e.g., nucleoside diphosphate kinase and succinyl thiokinase] in insulin secretion from the islet
cell [Diabetologia 44:89-94, 2001 and Arch. Biochem. Biophys. 398:160-169, 2002]. In this context, we also characterized an ATP- and GTP-sensitive, novel protein histidine kinase in isolated
cells that catalyzed the histidine phosphorylation of islet [endogenous] proteins as well as exogenously added histone 4 and we implicated this kinase in the activation of islet endogenous G- proteins [Biochem. Pharmacol. 63:2091-2100, 2002]. In the present study, we describe abnormalities in ATP-or GTP-mediated histidine phosphorylation of nucleoside diphosphate kinase in islets derived from the Goto-Kakizaki [GK] rat, a model for non-insulin-dependent diabetes. Further, we provide evidence for a marked reduction in the activities of ATP- or GTP-sensitive histidine kinases in GK rat islets. Based on these observations, we propose that alterations in protein histidine phosphorylation could contribute toward insulin secretory abnormalities demonstrable in the diabetic islet.
This article has been cited by other articles:
![]() |
A. Kowluru Regulatory roles for small G proteins in the pancreatic {beta}-cell: lessons from models of impaired insulin secretion Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E669 - E684. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |